CStone Pharmaceuticals CSPHF
$0.70
Last Updated: Aug 10, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
CStone Pharmaceuticals. Stock Analysis CSPHF
United States Health Care Small Cap Cstone Pharmaceuticals Co. Ltd. is an investment holding company, which engages in the research and development of complex biopharmaceutical products and sale of pharmaceutical products. Through its subsidiaries, the Company is primarily engaged in the research and development of biopharmaceutical products, the sales of pharmaceutical products, as well as the provision of license of its intellectual property (IP) or commercialization license. The Company’s products primarily include targeted therapies, AYVAKIT (avapritinib), GAVRETO (pralsetinib) and CEJEMLY (sugemalimab). The firm is also engaged in the development and commercialization of immuno-oncology. The firm primarily conducts its businesses in the domestic market and overseas markets, such as Central and Eastern Europe and Switzerland.
CStone Pharmaceuticals (CSPHF) Chart
Financial Metrics & Statements of CStone Pharmaceuticals (CSPHF)
FAQ's for CStone Pharmaceuticals (CSPHF)
- As of August 2026, CStone Pharmaceuticals CSPHF is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes CStone Pharmaceuticals using these criteria to determine its compliance status.
- Muslim investors may consider investing in CStone Pharmaceuticals if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of CStone Pharmaceuticals by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of CStone Pharmaceuticals may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of CStone Pharmaceuticals on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for CStone Pharmaceuticals (CSPHF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
